Cardiff Oncology clinical trials we track

Check company identity source

Phase 2 4 trials

Drugs in these trials

Names as written in the registry records.

Latest recorded trial changes

Filters
Clear filters

· 2 fields changed

Main study measure wording changed

Text changed; whether the study measures changed has not been verified. Saved text may be shortened.

Before: Measure: Overall Response Rate (ORR) Time frame: Up to 2 years. After: Measure: Overall Response Rate (ORR) Per Response Evaluation Criteria in Solid Tumors (RECIST) v1.1 Description: ORR was defined as the percentage of participants who achieved a best overall response of confirmed complete reponse (CR) or partial response (PR) determined by the Investigator per RECIST v1.1. According to RECIST 1.1, a CR is the disappearance of all target lesions, with non-target lesions non-existent and no new lesions and a PR is a decrease of at least 30% in the sum of the diameters of target lesions, as long as there are no new lesions and non-target lesions have not worsened. Two-sided 95% confidence interval (CI) was calculated using the exact binomial Clopper-Pearson method. Time frame: Up to approximately 91 weeks.

Recruitment status changed

Before: Completed. After: Terminated.

Check registry source